We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Leaving the door open

12 Mar 2004 By Robert Cyran

Sanofi s mean offer for fellow drugs maker Aventis has left the door open for other bidders. Novartis’s confirmed interest in Aventis should give Sanofi the push it needs to raise the cash portion of its bid.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)